Article

Scheduling Vaccinations: A New Online Tool for Parents and Pediatricians

According to a report by researchers at the CDC, up to 28% of toddlers haven't received vaccinations according to US guidelines.

I hope this posting finds readers refreshed after a relaxing Memorial Day weekend! Just in case you’re not back into the swing of things, here’s a reminder that the ASCO annual conference is under way this week, and if you’re not going, you can still listen in to the podcasts (the information on how to sign up is posted). The abstracts have been released and you can read about the pediatric presentations.

On another note, the Georgia Institute of Technology (known to those of us in the South as simply “Georgia Tech”) has recently announced the development of a downloadable tool for creating individualized vaccination schedules when a child has missed a vaccination.

According to a report by researchers at the CDC (published in the current issue of the American Journal of Preventive Medicine), up to 28% of toddlers haven’t received vaccinations according to US guidelines. Of the children that were not compliant with the recommended schedule, two thirds had missed an entire vaccine dose.

Maybe this isn’t news to you, especially when your staff has to sit down and manually figure out how to get these kids back on track. However, this new tool is supposed to eliminate — or at least, minimize - that headache. You can read more about the tool, and you can download it. It’s for children aged 6 years and younger.

The tool is an example of dynamic programming, in which multiple options are pared down to provide the optimal solution. I’m curious to hear about what the user experience is — if you’ve used it already, please let us know your impressions and if it really did save your office time!

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
© 2024 MJH Life Sciences

All rights reserved.